Indeed, increased levels of auto-antibodies binding to recombinant synuclein have been reported in early PD patients [16, 17, 22, 35] and in populations carrying genetic risk factors [1, 29], which might be in an asymptomatic early stage of PD. The gene discussed is SNCA; the disease is Parkinson disease.